Amazon is now more valuable than Microsoft. The e-commerce giant's market value increased to $702 billion, surpassing the tech company at $699.2 billion. Apple and Alphabet are still ahead of Amazon in being the most valuable companies. McDonald's is making Happy Meals healthier. The company says it will cap at least half of all children's offerings at 600 calories by 2022. It's removing the cheeseburger from the menu but will still offer them by request. Washington D.C. is reacting to the deadliest school shooting since Sandy Hook. Salon's Amanda Marcotte joins Cheddar to break down President Trump's address to the nation. He did not mention guns once in the speech. The fitness world's boxing trend is getting a new twist at Box + Flow. We talk to Founder Liv Young about why she's adding yoga to the boxing workout at her boutique studio. She left a high-profile branding job in the food industry to live her dream as an entrepreneur.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More